Syntheses and Biological Evaluation of Indolocarbazoles, Analogues of Rebeccamycin, Modified at the Imide Heterocycle
- 14 April 1998
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 41 (10) , 1631-1640
- https://doi.org/10.1021/jm970843+
Abstract
A series of 10 indolocarbazole derivatives, analogues to the antitumor antibiotic rebeccamycin, bearing modifications at the imide heterocycle were synthesized. They bear an N-methyl imide, N-methyl amide, or anhydride function instead of the original imide. Their inhibitory potencies toward topoisomerase I were examined using a DNA relaxation assay and by analyzing the drug-induced cleavage of 32P-labeled DNA. Protein kinase C (PKC) inhibition and interaction with DNA were also studied together with the in vitro antiproliferative activities against B16 melanoma and P388 leukemia cells. The antimicrobial activities against two Gram-positive bacteria (Bacillus cereus and Streptomyces chartreusis), a Gram-negative bacterium (Escherichia coli), and a yeast (Candida albicans) were tested as well as their antiviral activities toward HIV-1. The efficiency of the anhydride compounds was compared to that of the parent compound rebeccamycin and its dechlorinated analogue. All the compounds studied were inactive against PKC. The structural requirements for PKC and topoisomerase I inhibition are markedly different. In sharp contrast with the structure−PKC inhibition relationships, we found that an anhydride function does not affect topoisomerase I inhibition, whereas a methyl group on the indole nitrogen prevents the poisoning of topoisomerase I. The compounds exhibiting a marked toxicity to P388 leukemia cells had little or no effect on the growth of P388CPT5 cells which are resistant to the topoisomerase I inhibitor camptothecin. This study reinforces the conclusion that the DNA−topoisomerase I cleavable complex is the primary cellular target of the indolocarbazoles and significantly contributes to their cytotoxicity and possibly to their weak but noticeable anti-HIV-1 activities. The structure−activity relationships are also discussed.Keywords
This publication has 18 references indexed in Scilit:
- Syntheses and Biological Activities (Topoisomerase Inhibition and Antitumor and Antimicrobial Properties) of Rebeccamycin Analogues Bearing Modified Sugar Moieties and Substituted on the Imide Nitrogen with a Methyl GroupJournal of Medicinal Chemistry, 1997
- DNA Cleavage by Topoisomerase I in the Presence of Indolocarbazole Derivatives of RebeccamycinBiochemistry, 1997
- Structure−Activity Relationships in a Series of Substituted Indolocarbazoles: Topoisomerase I and Protein Kinase C Inhibition and Antitumoral and Antimicrobial PropertiesJournal of Medicinal Chemistry, 1996
- Control of Dissymmetry in the Synthesis of (+)-Tjipanazole F2Journal of the American Chemical Society, 1996
- The effect of Pyrrolo[3,4-c]carbazole derivatives on spinal cord ChAT activityBioorganic & Medicinal Chemistry Letters, 1995
- Rigid Analogs of Camptothecin as DNA Topoisomerase I InhibitorsJournal of Medicinal Chemistry, 1995
- DNA Topoisomerases I and II Cleavage Sites in the Type 1 Human Immunodeficiency Virus (HIV-1) DNA Promoter RegionBiochemical and Biophysical Research Communications, 1994
- Bicyclic imidazo derivatives, a new class of highly selective inhibitors for the human immunodeficiency virus type 1Antiviral Research, 1994
- Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinaseBiochemical and Biophysical Research Communications, 1986
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983